Advertisement
Scancell Holdings plc

Scancell Holdings plc (SCNLF) Stock Overview

Explore Scancell Holdings plc’s financial performance, market position, analyst ratings, and future outlook.

SCNLFPNK
HealthcareBiotechnology
$0.24
$0.09(26.84%)
U.S. Market opens in NaNh NaNm
Advertisement

Scancell Holdings plc (SCNLF)

Meyka AI Score

Z

Key Financials

Market Cap254.3M
P/E Ratio-34.34
EPS (TTM)$-0.01
ROE0.90%
Fundamental Analysis

AI Price Forecasts

1 Month$0.18
3 Months$0.21
1 Year Target$0.16

SCNLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Scancell Holdings plc (SCNLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 35.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -34.34 and a market capitalization of 254.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-26.84%
5-Day Change
-26.84%
1-Month Change
7.46%
3-Month Change
57.46%
6-Month Change
70.14%
Year-to-Date (YTD) Change
70.14%
1-Year Change
44.29%
3-Year Change
11.36%
5-Year Change
-2.00%
All-Time (Max) Change
-45.56%

Contact Information

44 18 6558 2066
Bellhouse Building, Oxford, NaN, OX4 4GD

Company Facts

61 Employees
IPO DateAug 2, 2013
CountryGB
Actively Trading

Frequently Asked Questions